RV-Online
Login
Order

Virus Genome Detection - Respiratory Virus Panel 2 for Multiplex Tests (432)

Samples:
1 set = 4 samples of 1.1 ml
Sample properties:
Lyophilised cell culture lysates

Dates:

Registration deadline:

Sample shipment:

Closing Date:

June (4) Nov. (6)
08.04.2022 09.09.2022
08.06.2022 09.11.2022
24.06.2022 25.11.2022
Shipping Information:
Shipping at ambient temperature
Parameters:
Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for simultaneous qualitative detection of influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated). This program will be completed with currently circulating virus variants. Some of the samples can contain chemically inactivated avian influenza A viruses.
Certificate Validity:
12 months
Safety Note:
Process as patient sample material. The participating laboratory must be authorized to perform direct and/or indirect detection of pathogens.
Additional Information:
The requirements of the RiliBÄK (Guidelines of the German Medical Association on quality assurance in medical laboratory testing / Bundesärztekammer) will be considered for the detection of the above-mentioned pathogens. Please note: Only results of multiplex tests will be accepted for EQA scheme 432 This multiplex EQA scheme is not suitable for (i) singleplex PCRs, (ii) tests for antigen detection, (iii) testing of sensitivity and (iv) typing. For this purpose, we refer to the INSTAND EQA schemes for the corresponding viruses.
EQAS Expert:

Prof. Dr. rer. nat. Heinz Zeichhardt

Institut für Qualitätssicherung in der Virusdiagnostik - IQVD

 

Potsdamer Chaussee 80

14129 Berlin

 

+49 30 8105 4300

Heinz.Zeichhardt@iqvd.de

Dr. rer. nat. Martin Kammel

Institut für Qualitätssicherung in der Virusdiagnostik - IQVD

 

Potsdamer Chaussee 80

14129 Berlin

 

+49 30 8105 4300

m.kammel@iqvd.de